Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1997 Oct 1;157(7):907–919.

Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy

J M Moutquin 1, P R Garner 1, R F Burrows 1, E Rey 1, M E Helewa 1, I R Lange 1, S W Rabkin 1
PMCID: PMC1228217  PMID: 9327800

Abstract

OBJECTIVE: To provide Canadian physicians with comprehensive, evidence-based guidelines for the nonpharmacologic management and prevention of gestational hypertension and pre-existing hypertension during pregnancy. OPTIONS: Lifestyle modifications, dietary or nutrient interventions, plasma volume expansion and use of prostaglandin precursors or inhibitors. OUTCOMES: In gestational hypertension, prevention of complications and death related to either its occurrence (primary or secondary prevention) or its severity (tertiary prevention). In pre-existing hypertension, prevention of superimposed gestational hypertension and intrauterine growth retardation. EVIDENCE: Articles retrieved from the pregnancy and childbirth module of the Cochrane Database of Systematic Reviews; pertinent articles published from 1966 to 1996, retrieved through a MEDLINE search; and review of original randomized trials from 1942 to 1996. If evidence was unavailable, consensus was reached by the members of the consensus panel set up by the Canadian Hypertension Society. VALUES: High priority was given to prevention of adverse maternal and neonatal outcomes in pregnancies with established hypertension and in those at high risk of gestational hypertension through the provision of effective nonpharmacologic management. BENEFITS, HARMS AND COSTS: Reduction in rate of long-term hospital admissions among women with gestational hypertension, with establishment of safe home-care blood pressure monitoring and appropriate rest. Targeting prophylactic interventions in selected high-risk groups may avoid ineffective use in the general population. Cost was not considered. RECOMMENDATION: Nonpharmacologic management should be considered for pregnant women with a systolic blood pressure of 140-150 mm Hg or a diastolic pressure of 90-99 mm Hg, or both, measured in a clinical setting. A short-term hospital stay may be required for diagnosis and for ruling out severe gestational hypertension (preeclampsia). In the latter case, the only effective treatment is delivery. Palliative management, dependent on blood pressure, gestational age and presence of associated maternal and fetal risk factors, includes close supervision, limitation of activities and some bed rest. A normal diet without salt restriction is advised. Promising preventive interventions that may reduce the incidence of gestational hypertension, especially with proteinuria, include calcium supplementation (2 g/d), fish oil supplementation and low-dose acetylsalicylic acid therapy, particularly in women at high risk for early-onset gestational hypertension. Pre-existing hypertension should be managed the same way as before pregnancy. However, additional concerns are the effects on fetal well-being and the worsening of hypertension during the second half of pregnancy. There is, as yet, no treatment that will prevent exacerbation of the condition. VALIDATION: The guidelines share the principles in consensus reports from the US and Australia on the nonpharmacologic management of hypertension in pregnancy.

Full Text

The Full Text of this article is available as a PDF (175.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton J. R., Stanziano G. J., Sibai B. M. Monitored outpatient management of mild gestational hypertension remote from term. Am J Obstet Gynecol. 1994 Mar;170(3):765–769. doi: 10.1016/s0002-9378(94)70279-9. [DOI] [PubMed] [Google Scholar]
  2. Beaufils M., Uzan S., Donsimoni R., Colau J. C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985 Apr 13;1(8433):840–842. doi: 10.1016/s0140-6736(85)92207-x. [DOI] [PubMed] [Google Scholar]
  3. Beilin L. Aspirin and pre-eclampsia. BMJ. 1994 May 14;308(6939):1250–1251. doi: 10.1136/bmj.308.6939.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Belfort M., Uys P., Dommisse J., Davey D. A. Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy. Br J Obstet Gynaecol. 1989 Jun;96(6):634–641. doi: 10.1111/j.1471-0528.1989.tb03276.x. [DOI] [PubMed] [Google Scholar]
  5. Belizán J. M., Villar J., Gonzalez L., Campodonico L., Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med. 1991 Nov 14;325(20):1399–1405. doi: 10.1056/NEJM199111143252002. [DOI] [PubMed] [Google Scholar]
  6. Belizán J. M., Villar J., Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Am J Obstet Gynecol. 1988 Apr;158(4):898–902. doi: 10.1016/0002-9378(88)90091-9. [DOI] [PubMed] [Google Scholar]
  7. Blumenthal I. Diet and diuretics in pregnancy and subsequent growth of offspring. Br Med J. 1976 Sep 25;2(6038):733–733. doi: 10.1136/bmj.2.6038.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bucher H. C., Guyatt G. H., Cook R. J., Hatala R., Cook D. J., Lang J. D., Hunt D. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA. 1996 Apr 10;275(14):1113–1117. doi: 10.1001/jama.1996.03530380055031. [DOI] [PubMed] [Google Scholar]
  9. Campbell D. M., MacGillivray I. The effect of a low calorie diet or a thiazide diuretic on the incidence of pre-eclampsia and on birth weight. Br J Obstet Gynaecol. 1975 Jul;82(7):572–577. doi: 10.1111/j.1471-0528.1975.tb00689.x. [DOI] [PubMed] [Google Scholar]
  10. Carruthers S. G., Larochelle P., Haynes R. B., Petrasovits A., Schiffrin E. L. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ. 1993 Aug 1;149(3):289–293. [PMC free article] [PubMed] [Google Scholar]
  11. Chari R. S., Frangieh A. Y., Sibai B. M. Chronic hypertension in pregnancy. Compr Ther. 1995 May;21(5):227–234. [PubMed] [Google Scholar]
  12. Crowther C. A., Bouwmeester A. M., Ashurst H. M. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol. 1992 Jan;99(1):13–17. doi: 10.1111/j.1471-0528.1992.tb14384.x. [DOI] [PubMed] [Google Scholar]
  13. Curet L. B., Olson R. W. Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy. Obstet Gynecol. 1979 Mar;53(3):336–340. [PubMed] [Google Scholar]
  14. Dawson E. B., McGanity W. J. Protection of maternal iron stores in pregnancy. J Reprod Med. 1987 Jun;32(6 Suppl):478–487. [PubMed] [Google Scholar]
  15. Eskenazi B., Fenster L., Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991 Jul 10;266(2):237–241. [PubMed] [Google Scholar]
  16. Fleming A. F., Hendrickse J. P., Allan N. C. The prevention of megaloblastic anaemia in pregnancy in Nigeria. J Obstet Gynaecol Br Commonw. 1968 Apr;75(4):425–432. doi: 10.1111/j.1471-0528.1968.tb00139.x. [DOI] [PubMed] [Google Scholar]
  17. Fletcher J., Gurr A., Fellingham F. R., Prankerd T. A., Brant H. A., Menzies D. N. The value of folic acid supplements in pregnancy. J Obstet Gynaecol Br Commonw. 1971 Sep;78(9):781–785. doi: 10.1111/j.1471-0528.1971.tb00338.x. [DOI] [PubMed] [Google Scholar]
  18. Gallery E. D., Hunyor S. N., Györy A. Z. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med. 1979 Oct;48(192):593–602. [PubMed] [Google Scholar]
  19. Girija A., Geervani P., Rao G. N. Influence of dietary supplementation during pregnancy on lactation performance. J Trop Pediatr. 1984 Apr;30(2):79–83. doi: 10.1093/tropej/30.2.79. [DOI] [PubMed] [Google Scholar]
  20. Haller H., Oeney T., Hauck U., Distler A., Philipp T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertens. 1989 Apr;2(4):238–243. doi: 10.1093/ajh/2.4.238. [DOI] [PubMed] [Google Scholar]
  21. Halligan A., O'Brien E., O'Malley K., Mee F., Atkins N., Conroy R., Walshe J. J., Darling M. Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J Hypertens. 1993 Aug;11(8):869–873. doi: 10.1097/00004872-199308000-00014. [DOI] [PubMed] [Google Scholar]
  22. Helewa M. E., Burrows R. F., Smith J., Williams K., Brain P., Rabkin S. W. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ. 1997 Sep 15;157(6):715–725. [PMC free article] [PubMed] [Google Scholar]
  23. Helewa M., Heaman M., Robinson M. A., Thompson L. Community-based home-care program for the management of pre-eclampsia: an alternative. CMAJ. 1993 Sep 15;149(6):829–834. [PMC free article] [PubMed] [Google Scholar]
  24. Hunt I. F., Murphy N. J., Cleaver A. E., Faraji B., Swendseid M. E., Coulson A. H., Clark V. A., Browdy B. L., Cabalum T., Smith J. C., Jr Zinc supplementation during pregnancy: effects on selected blood constituents and on progress and outcome of pregnancy in low-income women of Mexican descent. Am J Clin Nutr. 1984 Sep;40(3):508–521. doi: 10.1093/ajcn/40.3.508. [DOI] [PubMed] [Google Scholar]
  25. Hytten F. E. Weight gain in pregnancy--30 year of research. S Afr Med J. 1981 Jul 4;60(1):15–19. [PubMed] [Google Scholar]
  26. Imperiale T. F., Petrulis A. S. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA. 1991 Jul 10;266(2):260–264. [PubMed] [Google Scholar]
  27. Ito M., Koyama H., Ohshige A., Maeda T., Yoshimura T., Okamura H. Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol. Int J Gynaecol Obstet. 1994 Nov;47(2):115–120. doi: 10.1016/0020-7292(94)90350-6. [DOI] [PubMed] [Google Scholar]
  28. Iyengar L. Folic acid requirements of Indian pregnant women. Am J Obstet Gynecol. 1971 Sep;111(1):13–16. doi: 10.1016/0002-9378(71)90918-5. [DOI] [PubMed] [Google Scholar]
  29. JACOBSON H. N., BURKE B. S., SMITH C. A., REID D. E. Effect of weight reduction in obese pregnant women on pregnancy, labor, and delivery, and on the condition of the infant at birth. Am J Obstet Gynecol. 1962 Jun 15;83:1609–1616. doi: 10.1016/0002-9378(62)90178-3. [DOI] [PubMed] [Google Scholar]
  30. Janes S. L., Goodall A. H. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond) 1994 Jun;86(6):731–739. doi: 10.1042/cs0860731. [DOI] [PubMed] [Google Scholar]
  31. Josten L. E., Savik K., Mullett S. E., Campbell R., Vincent P. Bedrest compliance for women with pregnancy problems. Birth. 1995 Mar;22(1):1–14. [PubMed] [Google Scholar]
  32. Lopez-Jaramillo P., Narvaez M., Felix C., Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet. 1990 Feb 3;335(8684):293–293. doi: 10.1016/0140-6736(90)90112-i. [DOI] [PubMed] [Google Scholar]
  33. López-Jaramillo P., Narváez M., Weigel R. M., Yépez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol. 1989 Jun;96(6):648–655. [PubMed] [Google Scholar]
  34. Mabie W. C., Pernoll M. L., Biswas M. K. Chronic hypertension in pregnancy. Obstet Gynecol. 1986 Feb;67(2):197–205. doi: 10.1097/00006250-198602000-00008. [DOI] [PubMed] [Google Scholar]
  35. Mahomed K., James D. K., Golding J., McCabe R. Zinc supplementation during pregnancy: a double blind randomised controlled trial. BMJ. 1989 Sep 30;299(6703):826–830. doi: 10.1136/bmj.299.6703.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mathews D. D. A randomized controlled trial of bed rest and sedation or normal activity and non-sedation in the management of non-albuminuric hypertension in late pregnancy. Br J Obstet Gynaecol. 1977 Feb;84(2):108–114. doi: 10.1111/j.1471-0528.1977.tb12535.x. [DOI] [PubMed] [Google Scholar]
  37. Mathews D. D., Agarwal V., Shuttleworth T. P. A randomized controlled trial of complete bed rest versus ambulation in the management of proteinuric hypertension during pregnancy. Br J Obstet Gynaecol. 1982 Feb;89(2):128–131. doi: 10.1111/j.1471-0528.1982.tb04678.x. [DOI] [PubMed] [Google Scholar]
  38. Moodley J., Norman R. J. Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia. Prostaglandins Leukot Essent Fatty Acids. 1989 Sep;37(3):145–147. doi: 10.1016/0952-3278(89)90077-x. [DOI] [PubMed] [Google Scholar]
  39. Moutquin J. M., Desmarais L., Bastide A., Fraser W. D., Bureau M., Huot C., Fontaine J. Y., Forest J. C. Prédiction de la préclampsie: la tension artérielle ambulatoire. J Gynecol Obstet Biol Reprod (Paris) 1992;21(3):313–315. [PubMed] [Google Scholar]
  40. Nabeshima K. [Effect of salt restriction on preeclampsia]. Nihon Jinzo Gakkai Shi. 1994 Mar;36(3):227–232. [PubMed] [Google Scholar]
  41. Nisell H., Larsson G., Wager J. The relation between life stress and hypertensive complications during pregnancy. Acta Obstet Gynecol Scand. 1989;68(5):423–427. doi: 10.3109/00016348909021014. [DOI] [PubMed] [Google Scholar]
  42. O'Brien P. M., Broughton Pipkin F. The effects of deprivation of prostaglandin precursors on vascular sensitivity to angiotensin II and on the kidney in the pregnant rabbit. Br J Pharmacol. 1979 Jan;65(1):29–34. doi: 10.1111/j.1476-5381.1979.tb17330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Olsen S. F., Sørensen J. D., Secher N. J., Hedegaard M., Henriksen T. B., Hansen H. S., Grant A. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet. 1992 Apr 25;339(8800):1003–1007. doi: 10.1016/0140-6736(92)90533-9. [DOI] [PubMed] [Google Scholar]
  44. Onwude J. L., Lilford R. J., Hjartardottir H., Staines A., Tuffnell D. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol. 1995 Feb;102(2):95–100. doi: 10.1111/j.1471-0528.1995.tb09059.x. [DOI] [PubMed] [Google Scholar]
  45. Passaro K. T., Little R. E., Savitz D. A., Noss J. The effect of maternal drinking before conception and in early pregnancy on infant birthweight. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Epidemiology. 1996 Jul;7(4):377–383. doi: 10.1097/00001648-199607000-00007. [DOI] [PubMed] [Google Scholar]
  46. Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982 Jun;69(6):1366–1372. doi: 10.1172/JCI110576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rayburn W. F., Zuspan F. P., Piehl E. J. Self-monitoring of blood pressure during pregnancy. Am J Obstet Gynecol. 1984 Jan 15;148(2):159–162. doi: 10.1016/s0002-9378(84)80168-4. [DOI] [PubMed] [Google Scholar]
  48. Reynolds R. D., Styer D. J., Schlichting C. L. Decreased vitamin B-6 status of submariners during prolonged patrol. Am J Clin Nutr. 1988 Mar;47(3):463–469. doi: 10.1093/ajcn/47.3.463. [DOI] [PubMed] [Google Scholar]
  49. Richards S. R., Nelson D. M., Zuspan F. P. Calcium levels in normal and hypertensive pregnant patients. Am J Obstet Gynecol. 1984 May 15;149(2):168–171. doi: 10.1016/0002-9378(84)90191-1. [DOI] [PubMed] [Google Scholar]
  50. Rosenberg K., Twaddle S. Screening and surveillance of pregnancy hypertension--an economic approach to the use of daycare. Baillieres Clin Obstet Gynaecol. 1990 Mar;4(1):89–107. doi: 10.1016/s0950-3552(05)80214-7. [DOI] [PubMed] [Google Scholar]
  51. Rudnicki M., Frölich A., Rasmussen W. F., McNair P. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial. Acta Obstet Gynecol Scand. 1991;70(6):445–450. doi: 10.3109/00016349109007158. [DOI] [PubMed] [Google Scholar]
  52. Sanchez-Ramos L., Adair C. D., Kaunitz A. M., Briones D. K., Del Valle G. O., Delke I. Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial. Obstet Gynecol. 1995 Jun;85(6):915–918. doi: 10.1016/0029-7844(95)00052-s. [DOI] [PubMed] [Google Scholar]
  53. Sanchez-Ramos L., Briones D. K., Kaunitz A. M., Delvalle G. O., Gaudier F. L., Walker C. D. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol. 1994 Sep;84(3):349–353. [PubMed] [Google Scholar]
  54. Sehgal N. N., Hitt J. R. Plasma volume expansion in the treatment of pre-eclampsia. Am J Obstet Gynecol. 1980 Sep 15;138(2):165–168. doi: 10.1016/0002-9378(80)90028-9. [DOI] [PubMed] [Google Scholar]
  55. Sibai B. M., Caritis S. N., Thom E., Klebanoff M., McNellis D., Rocco L., Paul R. H., Romero R., Witter F., Rosen M. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993 Oct 21;329(17):1213–1218. doi: 10.1056/NEJM199310213291701. [DOI] [PubMed] [Google Scholar]
  56. Sibai B. M., Caritis S. N., Thom E., Shaw K., McNellis D. Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network. Am J Obstet Gynecol. 1995 May;172(5):1553–1557. doi: 10.1016/0002-9378(95)90495-6. [DOI] [PubMed] [Google Scholar]
  57. Sibai B. M., Villar M. A., Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol. 1989 Jul;161(1):115–119. doi: 10.1016/0002-9378(89)90246-9. [DOI] [PubMed] [Google Scholar]
  58. Sowers J. R., Zemel M. B., Bronsteen R. A., Zemel P. C., Walsh M. F., Standley P. R., Sokol R. J. Erythrocyte cation metabolism in preeclampsia. Am J Obstet Gynecol. 1989 Aug;161(2):441–445. doi: 10.1016/0002-9378(89)90539-5. [DOI] [PubMed] [Google Scholar]
  59. Spätling L., Spätling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 1988 Feb;95(2):120–125. [PubMed] [Google Scholar]
  60. Steegers E. A., Van Lakwijk H. P., Jongsma H. W., Fast J. H., De Boo T., Eskes T. K., Hein P. R. (Patho)physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study. Br J Obstet Gynaecol. 1991 Oct;98(10):980–987. doi: 10.1111/j.1471-0528.1991.tb15335.x. [DOI] [PubMed] [Google Scholar]
  61. Taufield P. A., Ales K. L., Resnick L. M., Druzin M. L., Gertner J. M., Laragh J. H. Hypocalciuria in preeclampsia. N Engl J Med. 1987 Mar 19;316(12):715–718. doi: 10.1056/NEJM198703193161204. [DOI] [PubMed] [Google Scholar]
  62. Taylor D. J., Mallen C., McDougall N., Lind T. Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol. 1982 Dec;89(12):1011–1017. doi: 10.1111/j.1471-0528.1982.tb04656.x. [DOI] [PubMed] [Google Scholar]
  63. Tinkanen H., Rorarius M., Metsä-Ketelä T. Catecholamine concentrations in venous plasma and cerebrospinal fluid in normal and complicated pregnancy. Gynecol Obstet Invest. 1993;35(1):7–11. doi: 10.1159/000292654. [DOI] [PubMed] [Google Scholar]
  64. Tuffnell D. J., Lilford R. J., Buchan P. C., Prendiville V. M., Tuffnell A. J., Holgate M. P., Jones M. D. Randomised controlled trial of day care for hypertension in pregnancy. Lancet. 1992 Jan 25;339(8787):224–227. doi: 10.1016/0140-6736(92)90017-w. [DOI] [PubMed] [Google Scholar]
  65. Villar J., Belizan J. M., Fischer P. J. Epidemiologic observations on the relationship between calcium intake and eclampsia. Int J Gynaecol Obstet. 1983 Aug;21(4):271–278. doi: 10.1016/0020-7292(83)90016-4. [DOI] [PubMed] [Google Scholar]
  66. Villar J., Repke J. T. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1124–1131. doi: 10.1016/0002-9378(90)90669-x. [DOI] [PubMed] [Google Scholar]
  67. Villar J., Repke J., Belizan J. M., Pareja G. Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstet Gynecol. 1987 Sep;70(3 Pt 1):317–322. [PubMed] [Google Scholar]
  68. Wallenburg H. C., Dekker G. A., Makovitz J. W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1–3. doi: 10.1016/s0140-6736(86)91891-x. [DOI] [PubMed] [Google Scholar]
  69. Walsh S. W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985 Jun 1;152(3):335–340. doi: 10.1016/s0002-9378(85)80223-4. [DOI] [PubMed] [Google Scholar]
  70. Zuspan F. P., Rayburn W. F. Blood pressure self-monitoring during pregnancy: practical considerations. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):2–6. doi: 10.1016/0002-9378(91)90613-v. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES